For more than 20 years, many women heard one simple message about menopause hormone therapy: it causes breast cancer, heart attacks, and dementia. Stay away. Then, in 2025, the FDA announced that it was initiating removal of broad boxed warnings from certain menopausal hormone therapy products and moving toward labeling that better reflects the risks of specific products and individual situations. So naturally, women started asking: Were hormones dangerous before and suddenly safe now? No. What changed is that we understand the evidence in a more detailed way. The better question is not simply, “Is hormone therapy safe?” The better question is, “Is hormone therapy safe and appropriate for me?”
Hormone Therapy Is Not One Thing
A lot of fear around hormone therapy goes back to the Women’s Health Initiative, or WHI, from the early 2000s. The message many women heard was, “Hormones cause breast cancer.” But the details matter. In long-term follow-up of the WHI randomized trials, women with prior hysterectomy who used estrogen alone had a lower risk of breast cancer incidence and breast cancer mortality compared with placebo. In contrast, women with a uterus who used estrogen plus medroxyprogesterone acetate, a specific synthetic progestin, had a higher risk of breast cancer incidence compared with placebo. That does not mean estrogen alone is right for every woman. It does mean the phrase “hormones cause breast cancer” is too broad to guide a personal decision. The type of hormone matters. Whether you need a progestogen matters. Your uterus status, breast cancer risk, family history, dose, route, and duration all matter.
Timing Matters Too
A healthy 52-year-old who recently entered menopause is not the same as someone starting systemic hormone therapy for the first time at 72. The Menopause Society’s 2022 hormone therapy position statement notes that for women younger than 60 or within 10 years of menopause onset, without contraindications, the benefit-risk ratio is favorable for treatment of bothersome vasomotor symptoms and prevention of bone loss. That does not mean every woman under 60 should take hormones. It means timing is one important part of the risk-benefit conversation.
Route and Dose Matter
Another common fear is blood clots and stroke. Systemic estrogen can increase blood clot risk, and some forms can increase stroke risk. But how estrogen is taken matters. Oral estrogen passes through the liver first, which can affect clotting-related proteins. Transdermal estrogen, such as a patch, gel, or spray, does not go through the liver the same way and may have a lower blood clot risk than oral estrogen. The dose also matters. A lower dose may carry different risks than a higher dose. This is why menopause care should not be one-size-fits-all.
Local Vaginal Estrogen Is Different
Low-dose vaginal estrogen is not the same as systemic hormone therapy. Systemic therapy circulates through the body and may be used for hot flashes, night sweats, sleep disruption related to vasomotor symptoms, and bone protection in some women. Low-dose vaginal estrogen is used mainly for vaginal dryness, painful sex, urinary discomfort, and recurrent urinary symptoms related to menopause. Because it is used locally, very little estrogen is absorbed into the bloodstream. The same word — estrogen — can describe very different treatments.
What Actually Changed in 2025?
In November 2025, the FDA announced it was initiating removal of broad “black box” warnings from menopausal hormone therapy products. The FDA later approved labeling changes to clarify risk considerations for several menopausal hormone therapy products. This does not mean hormone therapy is risk-free. It does mean older fear-based messaging was too broad.
Key Takeaways About Hormone Therapy Safety
- Hormone therapy is not one treatment.
- Estrogen alone and estrogen plus a progestogen are different decisions.
- Timing matters, especially whether therapy starts before age 60 or within 10 years of menopause.
- Route and dose matter.
- Low-dose vaginal estrogen is different from systemic hormone therapy.
- Personal medical history and goals matter most.
Bottom Line
Hormone therapy is not automatically safe for every woman, and it is not automatically dangerous for every woman.
At InTouch Primary Care in Sugar Land, TX, we help women understand their symptoms, risks, treatment options, and long-term health goals. Through our Direct Primary Care model, we have time for thoughtful, individualized conversations about menopause care.
Schedule your complimentary meet-and-greet here:
https://calendly.com/intouchprimarycare/15min?month=2024-02
FAQs: Hormone Therapy Safety
Is hormone therapy safe?
For many healthy symptomatic women, especially those under 60 or within 10 years of menopause, hormone therapy may be a safe and effective option. It still requires individualized review.
Does hormone therapy cause breast cancer?
Risk depends on the type of therapy, whether estrogen is used alone or with a progestogen, duration, baseline risk, and personal history.
Is vaginal estrogen the same as regular hormone therapy?
No. Low-dose vaginal estrogen is local treatment and has a different risk profile than systemic hormone therapy.
Schedule here
or call us to get started